INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$35,555,926
Cash & Equivalents
57%
Investments
32%
Receivables (Non-Related)
3%
Prepaid Expenses
3%
Other Assets
3%
Property, Plant, & Equipment (net)
1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$10,301,756
Deferred Revenue
74%
Payables & Accruals
20%
Other Liabilities
6%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$13,950,202
$20,257,885
+45%
Receivables (Non-Related)
$4,006,644
$1,243,579
-69%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$1,493,979
$1,157,558
-23%
Investments
$10,003,143
$11,384,927
+14%
Property, Plant, & Equipment (net)
$667,439
$479,869
-28%
Other Assets
$904,283
$1,032,108
+14%
Total Assets
$31,025,690
$35,555,926
+15%
Liabilities
2023
2024
Change
Payables & Accruals
$1,316,837
$2,045,691
+55%
Grants Payable
-
-
-
Deferred Revenue
$7,885,840
$7,634,196
-3%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$958,620
$621,869
-35%
Total Liabilities
$10,161,297
$10,301,756
+1%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$20,864,393
$25,254,170
+21%
Net assets
2023
2024
Change
Net assets
+$20,864,393
+$25,254,170
+21%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)